Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 446-640-8 | CAS number: -
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- yes
- Type of assay:
- other: in vitro mammalian cytogenicity (B10)
Test material
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: V79-cells of the Chinese hamster
- Metabolic activation:
- not specified
- Metabolic activation system:
- S9 liver fractions of rats, induced with phenobarbital/ß-naphthoflavone.
- Test concentrations with justification for top dose:
- Concentration range in the main test (with metabolic activation): 427.5 ... 1710 µg/ml
Concentration range in the main test (without metabolic activation): 427.5 ... 1710 µg/ml - Vehicle / solvent:
- Minimal Essential Medium (MEM)
- Details on test system and experimental conditions:
- Exposure period (with metabolic activation): 4 hours
Exposure period (without metabolic activation): 28 hours
Expression time:
Not applicable.
Selection time:
Not applicable.
Fixation time:
18 and 28 hours.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- other: as specified above
- Metabolic activation:
- with
- Genotoxicity:
- not specified
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (> 1710 µg/ml)
- Species / strain:
- other: as specified above
- Metabolic activation:
- without
- Genotoxicity:
- not specified
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- (> 1710 µg/ml)
- Additional information on results:
- Observations:
None. - Remarks on result:
- other: other: preliminary test
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
In conclusion, it can be stated that under the experimental conditions reported, the test item did
not induce structural chromosome aberrations as determined by the chromosome aberration
test in V79 cells (Chinese hamster cell line) in vitro.
Therefore, ucb 22060 is considered to be non-clastogenic in this chromosome aberration test
with and without S9 mix when tested up to the highest required test item concentration. - Executive summary:
The test item ucb 22060, dissolved in deionised water, was structural chromosome aberrations in V79 cells of the assessed for its potential to induce Chinese hamster in vitro in two independent experiments. The following study design was performed: without S9 mix with S9 mix exp. i exp. II exp. I exp. II Exposure period 4 hrs 18hra 28 hra 4 hra 4 hra Recovery 14 hra 14 hra 24 hra Preparation interval 18 hra 18 hra 28 hra 18hrs 28 hra In each experimental group two parallel cultures were set up. Per culture 100 metaphase plates were scored for structural chromosome aberrations. The highest applied concentration in the pre-test on toxicity (171 O pg/mL; approx. 10 mM) was chosen with respect to the current OECD Guideline 473. Dose selection of the cytogenetic experiments was performed considering the toxicity data. The chosen treatment concentrations are described in Table 2 (page 17). The evaluated experimental points and the results are summarised in Table 1 (page 10). No toxic effects indicated by reduced mitotic indices or reduced cell numbers were observed after treatment with the test item. In both independent experiments, neither a statistically significant nor a biologically relevant increase in the number of cells carrying structural chromosomal aberrations was observed after treatment with the test item. No increase in the frequencies of polyploid metaphrases was found after treatment with the test item as compared to the frequencies of the controls. Appropriate mutagens were used as positive controls. They induced statistically significant increases (p
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
